Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • UK
  • Clinic Portal Login
  • +44 (0)20 8068 8176
  • Request Information
  • +44 (0)20 8068 8176
United KingdomUnited Kingdom
  • Part of brands: |
  • Reproductive Health
    • Specialists
      • EndomeTRIO
      • ERA
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • PGT-A with ploidy
      • EMBRACE
      • PGT-SR
      • PGT-M
      • Infertility Panels
      • POC PORTFOLIO
      • NACE (NIPT)
      • SAT
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
  • User Manual
  • Send a Sample
  • Academy
Genetic Solutions > PGT-M

PGT-M Preimplantation Genetic Testing for Monogenic disorders

Prevent the transmission of single gene disorders to future children and achieve a healthy pregnancy

  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist

Igenomix has performed more than 1300 PGT-M cycles

Options for combined
PGT-M+PGT-A

Our PGT-M testing is 98% accurate.

Accredited testing
in a UK laboratory

Are you interested?

Request information
Or email us at info.uk@igenomix.com
Overview
  • What is PGT-M?
  • Indications
  • Limitations

What is PGT-M?

PGT-M (formerly PGD) is an early genetic diagnosis test for embryos produced during IVF, prior to their transfer to the uterus.

By analysing DNA from each embryo, normal embryos can be preferentially selected to be transferred and begin the journey towards conceiving a healthy child.

What is the procedure?

Who is PGT-M for?

  • Patients who are undergoing an assisted reproduction treatment and have a personal or familial high-risk for single gene conditions. This risk may be identified due to:
  • A family history of these conditions
  • A positive carrier screening result
  • A previous affected child
Download full disease list

For clinics in the UK, a condition must be approved by the Human Fertilisation & Embryology Authority (HFEA) to perform PGT-M. Igenomix are able to support clinics in their applications for additions to this list. Note that this restriction does not apply to non-UK clinics working with Igenomix UK.

Test limitations

  • Limitations of PGT-M can arise from the IVF treatment itself. For example, poor ovarian stimulation can reduce the likelihood of identifying a healthy embryo, since PGT-M success is linked to the number of high-quality eggs and embryos produced in the cycle.
  • Not all people who wish to have PGT-M are able to do so. It is essential that the disorder to be diagnosed has a comprehensive and accurate genetic characterization to at least identify the gene responsible for the condition. Regulatory restrictions (e.g. from the HFEA in the UK) may additionally limit which conditions can be tested.
  • PGT-M provides no guarantee of a completely healthy baby. If a couple is at high risk of transmitting a particular disease to their offspring, PGT-M significantly minimises this risk. However, there remains a small risk of misdiagnosis due to technical limitations, such as contamination, recombination and ADO. Couples should always be offered the possibility of prenatal diagnosis to confirm results. It is important to know that PGT-M will test for the specific mutation requested, but no other genes or mutations are analyzed, even if they are located within the same gene.
Documentation

Clinical Sheet

Download

Patient Brochure

Download
Scientific evidence

Relevant related studies:

Title: The clinical utility of PGD with HLA matching: a collaborative multi-centre ESHRE study

Authors: Kakourou G, Kahraman S, Ekmekci G C, Tac H A, Kourlaba G, Kourkouni E, Cervero Sanz A, Martin J, Malmgren H, Giménez C, Gold V, Carvalho F, Billi C, Chow J F C, Vendrell X, Kokkali G, Liss J, Steffann J, Traeger-Synodinos J

Publication: Hum Reprod. 2018 Mar 1;33(3):520-530. doi: 10.1093/humrep/dex384.

PMID: 29432583

Title: ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013

Authors: De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C

Publication: Hum Reprod. 2017 Oct 1;32(10):1974-1994. doi: 10.1093/humrep/dex265.

PMID: 29117384

If you're a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services you may be interested in

CGT

Determines the risk of having a child with a genetic disease

More information

PGT-A

Chromosomally normal
embryos selection

More information

NACE

Minimises unnecessary amniocentesis

More information

Igenomix is in the media

WE GUIDE YOU Fertility Inherited diseases prevention Healthy pregnancy
Click to view our ISO: 15189 accreditation
OUR SERVICES Genetic solutions For patients Sending samples and documentation
ABOUT US About Igenomix Contact User manual Work with us
FOLLOW IGENOMIX
  020 8068 8176 Email us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country
[2024] © Igenomix Privacy policy Quality policy Legal note Cookies policy       Complaints form

Request Information

Copyright 2025 © UX Themes
  • Reproductive Health
    • Specialists
      • EndomeTRIO
      • ERA
      • EMMA
      • ALICE
      • CGT
      • PGT-A
      • PGT-A with ploidy
      • EMBRACE
      • PGT-SR
      • PGT-M
      • Infertility Panels
      • POC PORTFOLIO
      • NACE (NIPT)
      • SAT
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
  • User Manual
  • Send a Sample
  • Academy
  • WooCommerce not Found
  • Newsletter
  • UK
  • Clinic Portal Login

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

United Kingdom
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.